Metastatic Carcinoma
Information
- Disease name
- Metastatic Carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04939246 | Active, not recruiting | N/A | Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction | June 18, 2021 | August 2025 |
| NCT02730923 | Active, not recruiting | Phase 1/Phase 2 | Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) | April 2016 | December 2024 |
| NCT04376502 | Active, not recruiting | N/A | Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma. | April 8, 2020 | December 2024 |
| NCT01320241 | Completed | Phase 2 | Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture | November 2008 | March 2012 |
| NCT01469598 | Completed | Phase 2 | Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer | August 2011 | January 2015 |
| NCT02192346 | Completed | Phase 1 | α-TEA in Advanced Cancer | August 4, 2014 | May 8, 2018 |
| NCT02960282 | Terminated | Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy | October 20, 2016 | April 13, 2022 | |
| NCT02605811 | Unknown status | Phase 2 | Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer | September 2015 | December 2021 |